Meeting
2023 ASCO Annual Meeting
Hypersensitivity reaction to taxanes following COVID-19 vaccination.
Authors
Bennett Osantowski
Cleveland Clinic Foundation, Cleveland, OH
Bennett Osantowski , Mariah Ondeck , Nerea Lopetegui-Lia , Yanwen Chen , Wei Wei , Sowmya Takkellapati , Halle C. F. Moore
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Track
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Sub Track
Pharmacology/Pharmacodynamics/Pharmacogenetics
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 3092)
DOI
10.1200/JCO.2023.41.16_suppl.3092
Abstract #
3092
Poster Bd #
290
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Quality Care Symposium
Analysis of increased paclitaxel hypersensitivity at a single institution in setting of COVID 19 vaccination.
First Author: Nikita Jain
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Impact of chemotherapy on COVID-19 vaccination in patients with gastrointestinal cancer.
First Author: Mitsukuni Suenaga
Poster
2022 ASCO Genitourinary Cancers Symposium
The effect of anti-cancer therapy on immunological response to COVID-19 vaccination.
First Author: Francesca Jackson-Spence
Poster
2024 ASCO Annual Meeting
The impact of COVID-19 mRNA vaccines on immune-related adverse events in patients with cancer receiving immune checkpoint inhibitors.
First Author: Mengni Guo